CAE State Key Laboratory of Medical Immunology develops marker-based method for liver cancer treatment by interferon

Jan 14, 2014

The team of Professor Xueta CAO found that only those hepatocellular carcinoma patients with high expression of liver retinoic acid inducible gene (RIG-I) responded well to an interferon treatment.

China Bio news release, January 14, 2013